First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer - François-Clément Bidard; Erica L. Mayer; Yeon Hee Park; Wolfgang Janni; Cynthia Ma; Massimo Cristofanilli; Giampaolo Bianchini; Kevin Kalinsky; Hiroji Iwata; Stephen Chia; Peter A. Fasching; Adam Brufsky; et al. (New England Journal of Medicine, 2025)